Clinical Trial Update: Antiarrhythmics or Ablation for Ventricular Tachycardia 2 [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing antiarrhythmic drugs versus ablation for ventricular tachycardia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Snippet

Sponsor: John Sapp | Conditions: Ventricular Tachycardia (VT) | Phase 4 | Status: COMPLETED